AC Immune SA (ACIU)

AC Immune Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	358	424	172	361	372	576
Market Cap Growth	50.06%	145.83%	-52.24%	-2.88%	-35.46%	6.20%
Enterprise Value	231	305	44	146	117	281
PE Ratio	-	-6.56	-2.26	-4.50	-5.28	12.29
PS Ratio	20.52	24.04	40.72	-	21.19	5.06
PB Ratio	2.12	2.22	0.95	1.42	1.52	2.05
P/FCF Ratio	-5.85	-5.77	-2.15	-4.84	-5.37	10.47
P/OCF Ratio	-5.96	-5.85	-2.19	-5.03	-5.52	10.11
EV/Sales Ratio	13.73	17.31	10.28	-	6.69	2.47
EV/EBITDA Ratio	-3.00	-4.94	-0.59	-1.90	-1.73	5.56
EV/EBIT Ratio	-2.88	-4.74	-0.57	-1.84	-1.67	5.76
EV/FCF Ratio	-3.55	-4.16	-0.54	-1.96	-1.70	5.11
Debt / Equity Ratio	0.02	0.02	0.02	0.01	0.01	0.01
Debt / EBITDA Ratio	-0.06	-0.07	-0.04	-0.04	-0.04	0.06
Debt / FCF Ratio	-0.08	-0.06	-0.04	-0.04	-0.04	0.05
Quick Ratio	7.48	8.73	10.71	9.92	16.14	16.50
Current Ratio	7.78	9.22	11.16	10.12	16.53	16.72
Asset Turnover	0.09	0.09	0.02	0	0.06	0.36
Interest Coverage	-473.57	-307.09	-198.27	-124.63	-335.53	24.59
Return on Equity (ROE)	-38.30%	-37.50%	-36.50%	-36.10%	-25.70%	16.80%
Return on Assets (ROA)	-33.60%	-33.30%	-33.50%	-32.30%	-23.40%	14.90%
Return on Capital (ROIC)	-37.92%	-32.67%	-41.24%	-33.64%	-28.14%	16.17%
Earnings Yield	-17.97%	-15.24%	-44.15%	-22.23%	-18.94%	8.14%
FCF Yield	-14.42%	-17.32%	-46.43%	-20.67%	-18.62%	9.55%
Buyback Yield / Dilution	-18.63%	-0.30%	-15.88%	-1.43%	-6.36%	-17.80%
Total Shareholder Return	-18.63%	-0.30%	-15.88%	-1.43%	-6.36%	-17.80%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).